Please login to read the full article.
Scrip Regulatory Affairs
RoHS recast: industry hammers case for medtech exemptions
09 June 2010
Amanda Maxwell
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU falsified meds directive published, but industry split over safety features
- Proposed new feature in future EU IVD Regulation: the classification rules
- EMA update on notified body consultations for drug/device borderline products reflects medtech views
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
